Trending...
- Agape Leadership Academy Opens Nationwide Enrollment — State ESA Scholarships Cover Full Tuition for Families in 7 States
- Revenue Optics Expands Its Private Equity Practice as Sponsors Move Inside Sales to the Center of Distribution Value Creation
- Boston Industrial Solutions Introduces New Natron® 310 Hyper White UV Ink for Enhanced Printing Performance
GREENSBORO, N.C., June 1, 2023 ~ Fuse Oncology, an oncology software solutions company, has announced the successful closing of its oversubscribed Series A. Cone Health Ventures and Northeast Georgia Health Ventures (NGHV) were among the largest contributors to the round. The investments will be used to accelerate the expansion of Fuse Oncology's first commercial product, S!GNAL, and develop additional solutions in the radiation oncology market.
James Bauler, CEO of Fuse Oncology, Inc., expressed his gratitude for the investors' enthusiasm and interest in their product. "We are grateful for the interest and enthusiasm of investors who understand the significant impact of our product and our potential to thrive in the market," said Bauler.
Fuse Oncology was spun out of Cone Health and signed its first revenues in quarter one of 2022. Their technology is designed to address key challenges that face radiation oncology departments by automatically identifying and tracking missing documentation, incomplete tasks and orders, as well as wrong charges entered.
More on ncarol.com
John Miller, chief investment officer at Cone Health, expressed his confidence in leading this funding round to support Fuse Oncology's growth. "Fuse has made phenomenal progress in establishing a foothold in the radiation oncology market," said Miller. "We are confident in leading this funding round to support their growth and help expand their reach."
S!GNAL technology from Fuse Oncology catches issues before they materialize to drastically improve revenue cycle and clinical staff workflows. By minimizing mistakes in coding and documentation processes, it has uncovered substantial lost revenues for providers. Additional solutions from Fuse address challenges in patient engagement cycles to reduce average time to treatment.
Stuart Burri, MD, chairman of radiation oncology at Levine Cancer Institute, president of Southeast Radiation Oncology Group (SERO), and an early investor continues to support Fuse Oncology's advancement. "Fuse's rapid expansion in local radiation oncology centers has changed the way we're thinking about business," said Dr Burri. "It's exciting to reimagine a seamless workflow and data experience between radiation oncology departments and health systems."
Fuse Oncology's Series A closing marks a major milestone for them as they continue their mission to make rad onc departments more efficient while supporting substantial growth in volumes and revenues throughout 2023.
James Bauler, CEO of Fuse Oncology, Inc., expressed his gratitude for the investors' enthusiasm and interest in their product. "We are grateful for the interest and enthusiasm of investors who understand the significant impact of our product and our potential to thrive in the market," said Bauler.
Fuse Oncology was spun out of Cone Health and signed its first revenues in quarter one of 2022. Their technology is designed to address key challenges that face radiation oncology departments by automatically identifying and tracking missing documentation, incomplete tasks and orders, as well as wrong charges entered.
More on ncarol.com
- Golden Visa Countries Outpace Eurozone Growth Over Eight Years, New La Vida Analysis Finds
- Allstream Energy Partners Announced as Official Media Partner for the 2nd Annual Permian Power Conference
- Children's Book for Kids with Limb Differences Coming Soon!
- CCHR Calls Out Psychiatry's Pattern of Resistance to Antidepressant Deprescribing
- Boston Industrial Solutions Introduces New Natron® 310 Hyper White UV Ink for Enhanced Printing Performance
John Miller, chief investment officer at Cone Health, expressed his confidence in leading this funding round to support Fuse Oncology's growth. "Fuse has made phenomenal progress in establishing a foothold in the radiation oncology market," said Miller. "We are confident in leading this funding round to support their growth and help expand their reach."
S!GNAL technology from Fuse Oncology catches issues before they materialize to drastically improve revenue cycle and clinical staff workflows. By minimizing mistakes in coding and documentation processes, it has uncovered substantial lost revenues for providers. Additional solutions from Fuse address challenges in patient engagement cycles to reduce average time to treatment.
Stuart Burri, MD, chairman of radiation oncology at Levine Cancer Institute, president of Southeast Radiation Oncology Group (SERO), and an early investor continues to support Fuse Oncology's advancement. "Fuse's rapid expansion in local radiation oncology centers has changed the way we're thinking about business," said Dr Burri. "It's exciting to reimagine a seamless workflow and data experience between radiation oncology departments and health systems."
Fuse Oncology's Series A closing marks a major milestone for them as they continue their mission to make rad onc departments more efficient while supporting substantial growth in volumes and revenues throughout 2023.
Filed Under: Business
0 Comments
Latest on ncarol.com
- Agape Leadership Academy Opens Nationwide Enrollment — State ESA Scholarships Cover Full Tuition for Families in 7 States
- Las Vegas Headliner Don Barnhart Brings National Touring Comedy Show to Comedy Cabana
- Nevada Boxing Hall of Fame Announces 14th Annual Induction Gala Weekend Honoring Classes of 2025 and 2026
- Brosix Celebrates 20 Years of Private Team Messaging for Small and Mid-Sized Businesses
- Top 15 Mosquito-Infested Cities in Louisiana and East Texas Ranked for 2026 Mosquito Season
- From Broken to Soaring Week 40
- Finnish Political Satire Film Generates 10,000+ Cross-Platform Interactions Following Gandalf Parody Video Across TikTok, YouTube and Telegram
- AI Is Making It Easier for API-First Platforms to Connect, Partner, Reach Customers, and Grow Revenue Faster
- 2026 Editorial Freelancers Association Conference Focuses on Building Sustainable Careers
- netElastic Powers LigaT's High-Performance Broadband Expansion and IPv6 Modernization in Portugal
- Raiku launches rkuSOL with Sanctum, Kamino, Loopscale and Exponent
- Greenland Mines Ltd (N A S D A Q: GRML) Advances Strategic Growth Initiatives as Critical Minerals Demand Accelerates
- Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029
- $97.9 Million Q1 Revenue Growth Reinforces Transformation Into a Global AI & Digital Services Powerhouse: IQSTEL, Inc. (N A S D A Q: IQST)
- Boston Industrial Solutions Launches Natron® 348 UV Inkjet Ink for Epson S3200 Print Heads
- Heritage at South Brunswick Unveils Luxury Resort-Style Amenities Designed for Every Generation
- CAPHRA warns push for ASEAN vape ban ignores science
- Your Mortgage Toolbox Launches Free Mortgage Calculators That Show the Real Monthly Payment and Cash Needed to Close
- ENTOUCH Recognized on Inc.'s 2026 Best Workplaces List for the Third Year Running
- P-Wave Classics Opens Pre-Orders for Volume II of Robert Bage's Hermsprong